Skip to content

Clinical trials

Phase 2 Kidney Neoplasms trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Kidney Neoplasms Phase: Phase 2 Country / region: United Kingdom Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20072
20082
20091
20101
20172
20181
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Unknown status4
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cancer Research UK2
Novartis Pharmaceuticals2
Apollomics Inc.1
AstraZeneca1
Barts and the London School of Medicine and Dentistry1
Bayer1
Calithera Biosciences, Inc1
Children's Cancer and Leukaemia Group1
Duke University1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Kidney Neoplasms14
Carcinoma, Renal Cell11
Neoplasms2
Brain Neoplasms1
Colonic Neoplasms1
Glioblastoma1
Lung Neoplasms1
Pancreatic Neoplasms1
Stomach Neoplasms1
Thyroid Neoplasms1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.